Literature DB >> 33445522

In Situ "Humanization" of Porcine Bioprostheses: Demonstration of Tendon Bioprostheses Conversion into Human ACL and Possible Implications for Heart Valve Bioprostheses.

Uri Galili1, Kevin R Stone2.   

Abstract

This review describes the first studies on successful conversion of porcine soft-tissue bioprostheses into viable permanently functional tissue in humans. This process includes gradual degradation of the porcine tissue, with concomitant neo-vascularization and reconstruction of the implanted bioprosthesis with human cells and extracellular matrix. Such a reconstruction process is referred to in this review as "humanization". Humanization was achieved with porcine bone-patellar-tendon-bone (BTB), replacing torn anterior-cruciate-ligament (ACL) in patients. In addition to its possible use in orthopedic surgery, it is suggested that this humanization method should be studied as a possible mechanism for converting implanted porcine bioprosthetic heart-valves (BHV) into viable tissue valves in young patients. Presently, these patients are only implanted with mechanical heart-valves, which require constant anticoagulation therapy. The processing of porcine bioprostheses, which enables humanization, includes elimination of α-gal epitopes and partial (incomplete) crosslinking with glutaraldehyde. Studies on implantation of porcine BTB bioprostheses indicated that enzymatic elimination of α-gal epitopes prevents subsequent accelerated destruction of implanted tissues by the natural anti-Gal antibody, whereas the partial crosslinking by glutaraldehyde molecules results in their function as "speed bumps" that slow the infiltration of macrophages. Anti-non gal antibodies produced against porcine antigens in implanted bioprostheses recruit macrophages, which infiltrate at a pace that enables slow degradation of the porcine tissue, neo-vascularization, and infiltration of fibroblasts. These fibroblasts align with the porcine collagen-fibers scaffold, secrete their collagen-fibers and other extracellular-matrix (ECM) components, and gradually replace porcine tissues degraded by macrophages with autologous functional viable tissue. Porcine BTB implanted in patients completes humanization into autologous ACL within ~2 years. The similarities in cells and ECM comprising heart-valves and tendons, raises the possibility that porcine BHV undergoing a similar processing, may also undergo humanization, resulting in formation of an autologous, viable, permanently functional, non-calcifying heart-valves.

Entities:  

Keywords:  anterior cruciate ligament reconstruction; anti-Gal antibody; anti-non gal antibody; bioprosthesis humanization; heart valve bioprosthesis; porcine tendon bioprosthesis; α-gal epitope; α-galactosidase

Year:  2021        PMID: 33445522      PMCID: PMC7826727          DOI: 10.3390/bioengineering8010010

Source DB:  PubMed          Journal:  Bioengineering (Basel)        ISSN: 2306-5354


  89 in total

1.  Major carbohydrate epitopes in tissues of domestic and African wild animals of potential interest for xenotransplantation research.

Authors:  R Oriol; J J Candelier; S Taniguchi; L Balanzino; L Peters; M Niekrasz; C Hammer; D K Cooper
Journal:  Xenotransplantation       Date:  1999-05       Impact factor: 3.907

2.  Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural alpha-galactosyl IgG antibodies.

Authors:  R Mañez; F J Blanco; I Díaz; A Centeno; E Lopez-Pelaez; M Hermida; H F Davies; A Katopodis
Journal:  Xenotransplantation       Date:  2001-02       Impact factor: 3.907

3.  Leukocytes, platelets, and surface microstructure of spontaneously degenerated porcine bioprosthetic valves.

Authors:  P D Stein; C H Wang; J M Riddle; D J Magilligan
Journal:  J Card Surg       Date:  1988-09       Impact factor: 1.620

4.  Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.

Authors:  U Galili; S B Shohet; E Kobrin; C L Stults; B A Macher
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

5.  Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves.

Authors:  Christopher G A McGregor; Alain Carpentier; Nermine Lila; John S Logan; Guerard W Byrne
Journal:  J Thorac Cardiovasc Surg       Date:  2011-01       Impact factor: 5.209

6.  Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum.

Authors:  Alex Zhu; Rosa Hurst
Journal:  Xenotransplantation       Date:  2002-11       Impact factor: 3.907

7.  Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.

Authors:  Andrew B Goldstone; Peter Chiu; Michael Baiocchi; Bharathi Lingala; William L Patrick; Michael P Fischbein; Y Joseph Woo
Journal:  N Engl J Med       Date:  2017-11-09       Impact factor: 91.245

8.  A structural difference between the cell surfaces of humans and the great apes.

Authors:  E A Muchmore; S Diaz; A Varki
Journal:  Am J Phys Anthropol       Date:  1998-10       Impact factor: 2.868

9.  Anti alpha-gal immune response following porcine bioprosthesis implantation in children.

Authors:  Chun Soo Park; Seong-Sik Park; Sun Young Choi; Sun Hee Yoon; Woong-Han Kim; Yong Jin Kim
Journal:  J Heart Valve Dis       Date:  2010-01

10.  Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man.

Authors:  D K Cooper; A H Good; E Koren; R Oriol; A J Malcolm; R M Ippolito; F A Neethling; Y Ye; E Romano; N Zuhdi
Journal:  Transpl Immunol       Date:  1993       Impact factor: 1.708

View more
  2 in total

Review 1.  Advances in Regenerative Sports Medicine Research.

Authors:  Liren Wang; Jia Jiang; Hai Lin; Tonghe Zhu; Jiangyu Cai; Wei Su; Jiebo Chen; Junjie Xu; Yamin Li; Jing Wang; Kai Zhang; Jinzhong Zhao
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

Review 2.  Can Heart Valve Decellularization Be Standardized? A Review of the Parameters Used for the Quality Control of Decellularization Processes.

Authors:  F Naso; A Gandaglia
Journal:  Front Bioeng Biotechnol       Date:  2022-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.